$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 79.47 | 1,317 | 104,662 | 62,305 | 63.6 K to 62.3 K (-2.07 %) |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 2,500 | 0 | 63,622 | 61.1 K to 63.6 K (+4.09 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 0 | |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 0 | |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.97 | 8,630 | 733,301 | 1,058,963 | 1.1 M to 1.1 M (-0.81 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.97 | 8,630 | 733,301 | 1,058,963 | 1.1 M to 1.1 M (-0.81 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.28 | 103,370 | 8,711,620 | 1,067,593 | 1.2 M to 1.1 M (-8.83 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.28 | 103,370 | 8,711,620 | 1,067,593 | 1.2 M to 1.1 M (-8.83 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 795 | 0 | 25,492 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 500,000 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 85.03 | 30,718 | 2,612,093 | 4,019,727 | 4.1 M to 4 M (-0.76 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 84.68 | 64,582 | 5,468,629 | 4,050,445 | 4.1 M to 4.1 M (-1.57 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.36 | 4,700 | 391,801 | 4,115,027 | 4.1 M to 4.1 M (-0.11 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 26,226 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 83.12 | 2,000 | 166,250 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 107 | 0 | 18,767 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 107 | 0 | 18,767 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 107 | 0 | 18,767 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 140 | 0 | 24,697 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 140 | 0 | 24,697 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 140 | 0 | 24,697 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 35 | 0 | 6,232 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 35 | 0 | 6,232 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 35 | 0 | 6,232 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 12 | 0 | 2,137 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 12 | 0 | 2,137 | |
| Jul 01 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 12 | 0 | 2,137 | |
| Jun 14 2016 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Option Exercise | A | 84.45 | 83,880 | 7,083,666 | 83,880 | |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 112,000 | |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 87.26 | 59,181 | 5,164,069 | 1,058,963 | 1.1 M to 1.1 M (-5.29 %) |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 86.57 | 52,819 | 4,572,710 | 1,118,144 | 1.2 M to 1.1 M (-4.51 %) |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 600,000 | |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 86.72 | 100,000 | 8,671,950 | 4,019,727 | 4.1 M to 4 M (-2.43 %) |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 28,226 | |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 87.02 | 2,000 | 174,040 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 3,865 | 311,712 | 16,906 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 5,795 | 467,367 | 0 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 4,232 | 105,398 | 30,226 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.30 | 43,200 | 1,049,544 | 0 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 86.85 | 57,092 | 4,958,600 | 61,122 | 118.2 K to 61.1 K (-48.30 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 3,865 | 311,712 | 118,214 | 114.3 K to 118.2 K (+3.38 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 5,795 | 467,367 | 114,349 | 108.6 K to 114.3 K (+5.34 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 4,232 | 105,398 | 108,554 | 104.3 K to 108.6 K (+4.06 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.30 | 43,200 | 1,049,544 | 104,322 | 61.1 K to 104.3 K (+70.68 %) |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 83.90 | 7,321 | 614,232 | 7,321 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 0.00 | 1,787 | 0 | 1,787 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 83.90 | 7,321 | 614,232 | 7,321 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 1,787 | 0 | 5,157 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Option Exercise | A | 83.90 | 7,321 | 614,232 | 7,321 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Option Exercise | A | 0.00 | 1,787 | 0 | 1,787 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 83.90 | 7,321 | 614,232 | 7,321 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 1,787 | 0 | 21,136 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 83.90 | 7,321 | 614,232 | 7,321 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 1,787 | 0 | 1,787 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 83.90 | 7,321 | 614,232 | 7,321 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 1,787 | 0 | 1,787 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 83.90 | 7,321 | 614,232 | 7,321 | |
| May 13 2016 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 0.00 | 1,787 | 0 | 1,787 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 0.00 | 1,466 | 0 | 0 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 0.00 | 1,466 | 0 | 45,775 | 44.3 K to 45.8 K (+3.31 %) |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | M | 0.00 | 1,466 | 0 | 0 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Buy | M | 0.00 | 1,466 | 0 | 39,285 | 37.8 K to 39.3 K (+3.88 %) |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 0.00 | 1,466 | 0 | 0 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 0.00 | 1,466 | 0 | 105,339 | 103.9 K to 105.3 K (+1.41 %) |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 0.00 | 1,466 | 0 | 0 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 0.00 | 1,466 | 0 | 91,543 | 90.1 K to 91.5 K (+1.63 %) |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Option Exercise | M | 0.00 | 1,466 | 0 | 0 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Buy | M | 0.00 | 1,466 | 0 | 16,761 | 15.3 K to 16.8 K (+9.58 %) |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 0.00 | 1,466 | 0 | 0 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 0.00 | 1,466 | 0 | 25,135 | 23.7 K to 25.1 K (+6.19 %) |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Option Exercise | M | 0.00 | 1,466 | 0 | 0 | |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Payment of Exercise | F | 84.68 | 419 | 35,481 | 838,652 | 839.1 K to 838.7 K (-0.05 %) |
| May 10 2016 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Buy | M | 0.00 | 1,466 | 0 | 839,071 | 837.6 K to 839.1 K (+0.18 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 34,458 | |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 6,620 | |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 88.72 | 2,000 | 177,448 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 63,122 | 62.9 K to 63.1 K (+0.29 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 62,939 | 61.1 K to 62.9 K (+2.97 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 224,000 | |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 88.14 | 57,329 | 5,052,789 | 1,058,963 | 1.1 M to 1.1 M (-5.14 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 87.27 | 54,671 | 4,771,166 | 1,116,292 | 1.2 M to 1.1 M (-4.67 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 700,000 | |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 88.26 | 48,982 | 4,322,960 | 4,019,727 | 4.1 M to 4 M (-1.20 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 87.40 | 51,018 | 4,458,733 | 4,068,709 | 4.1 M to 4.1 M (-1.24 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 800,000 | |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 93.54 | 72,374 | 6,769,777 | 4,019,727 | 4.1 M to 4 M (-1.77 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 92.73 | 21,025 | 1,949,728 | 4,092,101 | 4.1 M to 4.1 M (-0.51 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 91.50 | 6,601 | 604,002 | 4,113,126 | 4.1 M to 4.1 M (-0.16 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 91.23 | 5,000 | 456,158 | 142,090 | 147.1 K to 142.1 K (-3.40 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 336,000 | |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 94.88 | 15,836 | 1,502,444 | 1,058,963 | 1.1 M to 1.1 M (-1.47 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 94.54 | 96,164 | 9,091,460 | 1,074,799 | 1.2 M to 1.1 M (-8.21 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 34,641 | |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 91.34 | 2,000 | 182,680 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Apr 01 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 87 | 0 | 18,660 | |
| Apr 01 2016 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 29 | 0 | 6,196 | |
| Apr 01 2016 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 10 | 0 | 2,125 | |
| Apr 01 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 114 | 0 | 24,557 | |
| Apr 01 2016 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | A | 0.00 | 10 | 0 | 2,169 | |
| Mar 15 2016 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 90.00 | 5,000 | 450,000 | 147,090 | 152.1 K to 147.1 K (-3.29 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 36,641 | |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 87.90 | 2,000 | 175,800 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 448,000 | |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Sell | S | 87.79 | 112,000 | 9,832,995 | 1,058,963 | 1.2 M to 1.1 M (-9.56 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 900,000 | |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 88.86 | 73,826 | 6,560,112 | 4,019,727 | 4.1 M to 4 M (-1.80 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 87.79 | 26,174 | 2,297,742 | 4,093,553 | 4.1 M to 4.1 M (-0.64 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 0.00 | 169 | 0 | 24,443 | |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 0.00 | 169 | 0 | 15,288 | 15.1 K to 15.3 K (+1.12 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | J | 0.00 | 28,280 | 0 | 21,204 | 49.5 K to 21.2 K (-57.15 %) |